CION Ameerpet
Fertility & Hormones · Reviewed by CION Oncologists · NABH Accredited
Surgical Menopause — The Long View
The first months after ovary removal get some attention. The decade afterwards gets very little, and that is where most of the consequence sits. A woman put into menopause at forty-five faces the same symptoms as anyone else and roughly ten additional years of them, plus that many more years of the bone and cardiovascular effects of losing oestrogen early. This page is about that longer horizon: what persists, what can be done about it, and the question that most often goes unanswered — who is actually responsible for managing it once the cancer follow-up moves on.
- It lasts longer than a natural menopause — more years of symptoms, and more years without oestrogen
- The silent effects matter most — bone and cardiovascular risk, invisible now and real later
- More is treatable than women are told — including options frequently refused without consideration
- Somebody should own it — and it commonly falls between oncology and general practice
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Persists, and Over What Timescale
Some of this settles within a couple of years. Some of it does not, and some of it only becomes visible much later.
| Effect | How long | What is available |
|---|---|---|
| Hot flushes and night sweats | Often several years, and longer after surgical than natural menopause. | Non-hormonal medications work well and are frequently the first offer. HRT where appropriate. Cognitive behavioural approaches have evidence specifically for this. |
| Sleep disturbance | Tracks the flushes, and can persist independently. | Treating flushes often resolves it. Sleep-specific approaches and treating anxiety where relevant. |
| Vaginal dryness and discomfort | Does not resolve on its own — it progresses without treatment. | Moisturisers, lubricants, and local vaginal oestrogen which is highly effective and badly under-used. See vaginal health. |
| Reduced libido | Frequently persistent, and rarely raised in an oncology clinic. | Treating discomfort first, since pain suppresses desire. Psychosexual services. See intimacy after treatment. |
| Mood, anxiety, concentration | Variable, and easily attributed entirely to the cancer. | Worth distinguishing hormonal from situational causes, since the treatments differ. Psycho-oncology support. |
| Bone density loss | Silent for decades, then presents as fracture. | Assessment, calcium and vitamin D, weight-bearing exercise, specific bone treatment where indicated. See bone health. |
| Cardiovascular risk | Silent, accumulating, and greater the younger you were. | Blood pressure, lipids, blood sugar, weight and activity actively reviewed rather than assumed. |
Notice which rows say “silent”. The symptoms that bother you now generally improve with time or treatment. The two consequences that will matter most in twenty years produce no symptoms at all today, which is exactly why they get neglected — and why they are worth raising at an appointment where nothing feels wrong.
Did You Know? The age at which the ovaries are removed matters more than almost anything else about surgical menopause, and it works in a straightforward way: every year of lost oestrogen before the natural menopause adds to the cumulative deficit. A woman who has her ovaries removed at fifty-two loses very little she would not soon have lost anyway. A woman of forty loses more than a decade of hormone exposure her body was expecting, and the consequences for bone density and cardiovascular risk scale accordingly. This is why guidance treats early surgical menopause as a condition requiring active management rather than as an expected consequence to be absorbed — and why the case for treating it is strongest in exactly the women most often told nothing can be done. Sources: NICE guideline NG23 on menopause: diagnosis and management; British Menopause Society guidance on premature ovarian insufficiency and on HRT after gynaecological cancer; NCCN Clinical Practice Guidelines in Oncology — Survivorship.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Who Is Actually Managing This?
This is the practical question that determines whether anything on this page happens, and it frequently has no answer.
Oncology follow-up is focused on whether the cancer has returned, and menopause can feel outside its remit. General practice may defer anything hormonal after a cancer to oncology. Meanwhile the woman in the middle endures treatable symptoms while each assumes the other is handling it.
- Ask directly, and expect a name. “Who is managing my menopause?” is a reasonable question with a factual answer, and asking it frequently produces one where none existed.
- Bring it to an appointment where nothing is wrong. The bone and cardiovascular questions are exactly the ones that never come up in a consultation dominated by a symptom.
- Ask for referral to a menopause service if one is available. Menopause after gynaecological cancer is a recognised specialist area, and services experienced in it exist.
- Do not accept “it is expected” as an endpoint. Expected and untreatable are different things, and the first is often offered as though it meant the second.
Nobody Managing Your Menopause?
It commonly falls between specialties. Symptoms, bone and cardiovascular risk are all worth reviewing together.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
The Effects That Matter Most Are the Ones You Cannot Feel
Bone and cardiovascular risk are silent now, modifiable now, and expensive to ignore.
Options in order of what most women are offered
What Is Actually Available
A good deal exists, and much of it is not offered because nobody asked. Each of these is worth raising by name.
Non-hormonal treatment of hot flushes
Several medications reduce vasomotor symptoms without hormones, and they are usually the first thing offered after cancer treatment. They are genuinely effective for a substantial proportion of women, though less so than hormone replacement, and they have their own side effects worth discussing. Cognitive behavioural approaches also have specific evidence for menopausal symptoms and are under-used. If you have been told nothing can be done because of your cancer history, this is the category most obviously overlooked — it has nothing to do with hormones at all.
Local vaginal oestrogen
The most under-used effective treatment in this whole area. A low dose applied vaginally as a cream, pessary or ring treats dryness, discomfort, pain with intercourse and urinary symptoms, with minimal absorption into the bloodstream and a substantially different risk profile from systemic hormone replacement. It is frequently refused as part of a blanket no to hormones after cancer, which conflates two quite different questions. Vaginal symptoms do not improve on their own and progress without treatment, so this matters more than its low profile suggests.
Systemic hormone replacement, where appropriate
Not automatically forbidden after endometrial cancer, and blanket refusals are common and frequently unjustified. Whether it is appropriate depends on the stage, grade and histological type of your cancer, and on how much you are suffering. For some women with early low-grade disease it is a reasonable option after discussion; for others it is not. What is not reasonable is a refusal issued without the question being considered — particularly for a woman put into surgical menopause young, where the stakes over decades are considerable. See HRT after endometrial cancer.
Bone protection
The intervention with the longest payoff and the least urgency-driven attention. Bone density assessment establishes a baseline; adequate calcium and vitamin D, and weight-bearing exercise, slow loss; and specific bone treatment is available where density is already low or risk is high. All of it works better started early than started after a fracture, and a woman entering menopause a decade prematurely has a decade more of loss to plan for. Ask for a bone density scan rather than waiting to be offered one.
Cardiovascular risk review
Rarely mentioned in cancer follow-up and arguably more consequential than anything else on this page for long-term survival. Early loss of ovarian hormones is associated with increased cardiovascular risk, more pronounced the younger the woman. Blood pressure, lipids, blood sugar, weight and physical activity all warrant active review rather than assumption. For many women treated successfully for early endometrial cancer, cardiovascular disease is a greater long-term threat than the cancer was.
Psychological and sexual health support
Mood change, anxiety and loss of libido after surgical menopause are common, treatable, and among the least likely things to be raised in an oncology clinic. Psycho-oncology exists for this and asking is not a comment on how well you are coping. Psychosexual services address the intimacy consequences specifically, which are frequently a combination of physical discomfort, hormonal change and understandable anxiety after cancer — and which respond better to being addressed together than separately.
Want Someone to Take This On Properly?
Symptoms, bone density, cardiovascular risk, and a considered answer on hormone treatment. The opinion is free.
Weight, Which Matters Twice Over Here
Weight gain after surgical menopause is common, harder to reverse than before it, and carries a particular significance in this disease that it would not carry elsewhere.
- It is harder for physiological reasons. Metabolic rate falls, muscle mass declines, fat redistributes centrally, and disrupted sleep independently impairs weight regulation and appetite signalling. This is not a failure of resolve.
- And it matters more in endometrial cancer. Excess body weight produces oestrogen and is associated with poorer outcomes in this disease specifically, so weight gain after treatment is a clinical issue rather than a cosmetic one. See weight management after endometrial cancer.
- Which makes it a reason to ask for support. Structured help, attention to insulin resistance, and realistic goals work considerably better than a diet sheet handed over at a follow-up appointment.
- Activity helps even where weight does not move. It improves insulin sensitivity, bone density, cardiovascular risk, mood and sleep independently of the scales, which makes it the highest-value single change available. See exercise and activity.
For the broader picture of life after treatment, of which this is one part, see life after endometrial cancer treatment and managing early menopause after treatment.
Why This Needs an Owner
It sits between oncology and general practice, and a woman in that gap can lose a decade to treatable symptoms.
Survivorship care that is actually offered
45-minute consultations
Follow-up you can actually keep
Psycho-oncology and nutrition on the team
One place for the whole pathway
Decisions for healing, not billing
Take The Next Step
Raise the Silent Ones When Nothing Feels Wrong
Bone and heart risk never come up in an appointment about a symptom. Bring them anyway.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Surgical Menopause — Frequently Asked Questions
How long does surgical menopause last?
Menopause itself is permanent — the ovaries are not coming back — but the symptoms follow a different course from the underlying hormone loss. Hot flushes and night sweats often persist for several years, and typically for longer after surgical than after natural menopause because the fall is abrupt rather than gradual. Sleep disturbance tracks them. Vaginal dryness and discomfort behave differently again: they do not resolve on their own and progress without treatment. And the two consequences that matter most over decades — bone density loss and increased cardiovascular risk — are silent throughout, which is precisely why they get neglected.
Why does age at surgery matter so much?
Because the deficit is cumulative. A woman whose ovaries are removed at fifty-two loses very little hormone exposure she would not soon have lost anyway. A woman of forty loses more than a decade of oestrogen her body was expecting, and the consequences for bone density and cardiovascular risk scale with that lost time. This is why guidance treats early surgical menopause as a condition warranting active management rather than as an expected consequence to be absorbed — and why the argument for treating it is strongest in exactly the younger women who are most often told nothing can be done because of their cancer history.
What can I take if hormone replacement is not an option?
A good deal, and this is the category most often overlooked when a blanket no to hormones is issued. Several non-hormonal medications reduce hot flushes effectively, and cognitive behavioural approaches have specific evidence for menopausal symptoms. Local vaginal oestrogen is a separate question from systemic HRT — minimal absorption, different risk profile, highly effective for dryness and urinary symptoms — and is frequently refused as part of the same general prohibition when it should be considered on its own terms. Bone protection through assessment, calcium, vitamin D, weight-bearing exercise and specific bone treatment does not involve hormones at all.
Who should be looking after my menopause after cancer treatment?
This is worth asking directly, and it frequently has no answer by default. Oncology follow-up focuses on whether the cancer has returned and may regard menopause as outside its remit; general practice may defer anything hormonal after cancer back to oncology; and the woman in the middle endures treatable symptoms while each assumes the other is handling it. Ask "who is managing my menopause?" and expect a name rather than a shrug. If nobody has taken ownership, request referral to a service experienced in menopause after gynaecological cancer — the bone and cardiovascular consequences alone justify it.
Why is weight harder to manage after surgical menopause?
For reasons that are physiological rather than a matter of willpower. Metabolic rate declines, muscle mass falls, fat redistributes centrally, and the disrupted sleep that accompanies menopausal symptoms independently interferes with appetite signalling and weight regulation. Many women also have some degree of insulin resistance. In endometrial cancer this carries additional weight — excess body fat produces oestrogen and is associated with poorer outcomes in this disease specifically, so it is a clinical issue rather than a cosmetic one. That is a reason to ask for structured support rather than to accept a diet sheet, and activity helps meaningfully even when the scales do not move.
Medical disclaimer: This page describes the longer-term management of surgical menopause after treatment for endometrial cancer and is reviewed by a CION oncologist, following NICE guidance on menopause, British Menopause Society guidance, and current NCCN survivorship guidance. Whether systemic hormone replacement is appropriate depends on the stage, grade and histology of your cancer and should be decided with your oncology team. It is general health information rather than advice about your own care.